These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 9386346)
61. Immunobiology of the decidual tissue. Lala PK; Kearns M Contrib Gynecol Obstet; 1985; 14():1-15. PubMed ID: 3905249 [No Abstract] [Full Text] [Related]
62. Human peripheral blood monocytes are susceptible to interferon-activated natural killer cells. Einhorn S; Anderbring E J Clin Lab Immunol; 1985 Apr; 16(4):197-9. PubMed ID: 4020850 [TBL] [Abstract][Full Text] [Related]
63. Requirement for monocytes in the spontaneous cytotoxic effects of human lymphocytes against non-lymphoid target cells. de Vries JE; Mendelsohn J; Bont WS Nature; 1980 Feb; 283(5747):574-6. PubMed ID: 7354840 [TBL] [Abstract][Full Text] [Related]
64. Human CD4 modulation in vivo induced by antibody treatment. Horneff G; Guse AH; Schulze-Koops H; Kalden JR; Burmester GR; Emmrich F Clin Immunol Immunopathol; 1993 Jan; 66(1):80-90. PubMed ID: 8440076 [TBL] [Abstract][Full Text] [Related]
65. Enhancement of defective monocyte function during immunotherapy with recombinant interferon. Nielsen H; Ernst P Cancer Immunol Immunother; 1986; 22(2):144-7. PubMed ID: 3719594 [TBL] [Abstract][Full Text] [Related]
66. Use of cellular and cytokine adjuvants in the immunotherapy of cancer. Salgaller ML; Lodge PA J Surg Oncol; 1998 Jun; 68(2):122-38. PubMed ID: 9624043 [TBL] [Abstract][Full Text] [Related]
67. Partial review of immunotherapeutic pharmacology in stem cell transplantation. Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081 [TBL] [Abstract][Full Text] [Related]
68. [The efficacy of combined immunomodulatory therapy with timoptin and sodium nucleinate in patients with chronic obstructive bronchitis]. Zemskov AM; Zemskov VM; Nikitin AV; Zazhireĭ VD; Evstratova EF Ter Arkh; 1989; 61(3):65-8. PubMed ID: 2741121 [TBL] [Abstract][Full Text] [Related]
69. Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor. Oppenheim JJ; Togawa A; Chedid L; Mizel S Cell Immunol; 1980 Mar; 50(1):71-81. PubMed ID: 6967358 [No Abstract] [Full Text] [Related]
71. The adjuvant PCEP induces recruitment of myeloid and lymphoid cells at the injection site and draining lymph node. Awate S; Wilson HL; Singh B; Babiuk LA; Mutwiri G Vaccine; 2014 May; 32(21):2420-7. PubMed ID: 24662707 [TBL] [Abstract][Full Text] [Related]
72. Contribution of zinc to reduce CD4+ risk factor for 'severe' infection relapse in aging: parallelism with HIV. Mocchegiani E; Muzzioli M; Gaetti R; Veccia S; Viticchi C; Scalise G Int J Immunopharmacol; 1999 Apr; 21(4):271-81. PubMed ID: 10408635 [TBL] [Abstract][Full Text] [Related]
73. Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency. Allen JI; Perri RT; McClain CJ; Kay NE J Lab Clin Med; 1983 Oct; 102(4):577-89. PubMed ID: 6604771 [TBL] [Abstract][Full Text] [Related]
75. [The effect of the yeast polysaccharide rodexman on the function of the immunocompetent cells in patients with pulmonary tuberculosis]. Podgaĭnaia EA Lik Sprava; 1993 Jul; (8):83-5. PubMed ID: 8079487 [TBL] [Abstract][Full Text] [Related]
76. Use of Vaccinia virus as an adjuvant in inducing specific anti-tumour immunity to transplantable mouse fibrosarcoma. II. Rejection of tumour graft 'in vivo' humoral and lymphocytotoxicity 'in vitro'. Bendre AR; Gangal SG Indian J Cancer; 1978 Dec; 15(4):9-16. PubMed ID: 757692 [No Abstract] [Full Text] [Related]